Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States
美国新冠肺炎诊断后发生神经系统或免疫介导不良事件的风险
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0333704
Fisher, Shelby S; Lindaas, Arnstein; Muthuri, Stella G; Lloyd, Patricia C; Gruber, Joann F; Richey, Morgan M; Lyu, Hai; Cheng, Angela S; Kowarski, Lisa S; McKillop, Mollie M; Bui, Christine; Clarke, Tainya C; Beers, Jeffrey; Burrell, Timothy; Duenas, Pablo Freyria; Chen, Yangping; Sheng, Minya; Forshee, Richard A; Anderson, Steven A; Chillarige, Yoganand; Anthony, Mary S; Shoaibi, Azadeh; Layton, J Bradley